Medical Writing Visual Communications Planting a “non-biological” seed – will this meme persist?

Volume 29, Issue 1 - Visual Communications

Planting a “non-biological” seed – will this meme persist?


Some word uses persist and some do not. Part of what makes use of a word stick is how catchy it is. This word is already used on our supermarket shelves. This proposed new use illuminates a small way in which language evolves. And it helps to compartmentalise differences between chemical and biological manufacture of pharmaceuticals. The question is, will this word use persist enough to enter common vocabulary? The word is nonbiological.

Download the full article


  1. Darwin Correspondence Project, “Letter no. 5140,” [cited 2019 Oct 17]. Available from: letter/ DCP-LETT-5145.xml# mark- 5145.f3.
  2. Survival of the fittest. Wikipedia [cited 2019 Oct 17]. Available from: of_the_fittest.
  3. Dawkins R. The Selfish Gene. Oxford: Oxford University Press; 1976.
  4. Cavalli-Sforza LL. Genes, Peoples and Languages. Allen Lane: The Penguin Press; 2000.
  5. Internet meme. Wikipedia [cited 2020 Jan 01]. Available from: meme.
  6. French C. Personal communication at The University of Edinburgh. 2004.
  7. The IBN SINA Pharmaceutical Industry Ltd. Bactin® (ciprofloxacin USP) [cited 2019 Oct 20]. Available from: /pharma/general/by-brandname/ detail/bactin/.
  8. Walsh G. Bio-pharmaceutical Benchmarks. Nat. Biotechnol. 2018;36(12):1136–45
  9. The Motley Fool. What Is a Small-Molecule Drug? 2016 [cited 2020 Jan 01]. Available from: what-is-a-small-molecule-drug.aspx.
  10. Thierauch K-H. Small Molecule Drugs. In: Schwab M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg; 2011.
  11. Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–82.
  12. US FDA. Non-Biological Complex Drugs – Challenges for approval standards and opportunities!! [cited 2020 Jan 01]. Available from: media/125176/download.
  13. Hussaarts L, Műhlebach S, Shah VP, et al. Equivalence of complex drug products: advances in and challenges for current regulatory frameworks, Ann. N. Y. Acad. Sci. 2017;1407: 39–49.
  14. Karshikoff A, Nilsson L, Ladenstein R. Rigidity versus flexibility: the dilemma of understanding protein thermal stability. FEBS J. 2015;282(20):3899–917.
  15. Rader R, Langer E. Top trends in the biopharmaceutical Industry and bioprocessing for 2019, 2018 [cited 2020 Jan 01]. Available from: top-trends-in-the-biopharmaceuticalindustry- and-bioprocessing-for-0001.
  16. Radovan D. Biosimilar development – an overview. MEW. 2019;28(2):20–7.
  17. European Medical Writers Association. Generics and biosimilars. Med Writ. 2019;28(2).
  18. Thambavita D, Galappatthy P, Jayakody RL. Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities. J Pharm Policy and Pract. 2018;11:14;1–8.
  19. Benet LZ. The role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in drug development. J Pharm Sci. 2013;102(1);34–42.
  20. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3);413–20.
  21. Crommelin DJA, de Vlieger JSB, Weinstein V, Műhlebach S, Shah VP, Schellekens H. Different pharmaceutical products need similar terminology. AAPS J. 2014;16(1);11–4.
  22. Geigert J. Biologics are not chemical drugs. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics, 3rd ed. Springer New York; 2019;33–51.



President's Message
Medical illustration in the 21st century and beyond
Visualisations in science communication: Friend or foe?
How and why it works: The principles and history behind visual communication
Get your (visual) act together: Optimising the design of labels and arrows in medical illustrations
A picture is worth a thousand words
The evolution of the scientific poster: From eye-sore to eye-catcher
Leveraging infographics in study schemas
Enhancing accessibility of study data: The development of a graphical abstract for lay summaries of clinical trial results
Connecting medical writers in Portugal through visual communication
Clinical trial design: Considerations for medical writers developing clinical trial protocols
Planting a “non-biological” seed – will this meme persist?
Regulatory Matters
News from the EMA
Journal Watch
Getting Your Foot in the Door
Veterinary Medical Writing
Good Writing Practice
Medical Writing Humour
Out on our Own


The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board


Raquel Billiones


Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir


Jennifer Bell


Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer


Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha


Tiziana von Bruchhausen


Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk